Isavuconazole in the Treatment of Coccidioidal Meningitis

Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02232-18. doi: 10.1128/AAC.02232-18. Print 2019 Mar.

Abstract

Patients with coccidioidal meningitis require lifelong antifungal therapy. Cumulative toxicity and lack of antifungal efficacy require salvage therapy in the treatment of some patients. In a retrospective review of nine patients with coccidioidal meningitis treated with isavuconazole, successful therapy was seen in three patients and stable disease was confirmed in six patients. Isavuconazole may be a useful addition to the therapeutic choices currently available for coccidioidal meningitis.

Keywords: coccidioides; isavuconazole; meningitis.

MeSH terms

  • Adult
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Coccidioidomycosis / drug therapy*
  • Female
  • Humans
  • Male
  • Meningitis, Fungal / drug therapy*
  • Middle Aged
  • Nitriles / adverse effects
  • Nitriles / therapeutic use*
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Retrospective Studies
  • Treatment Outcome
  • Triazoles / adverse effects
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Nitriles
  • Pyridines
  • Triazoles
  • isavuconazole